B-Raf-IN-21
B-Raf-IN-21 is a B-Raf kinase inhibitor with a Kd of 4.8 nM and an IC50 of 6 nM. B-Raf-IN-21 can be used for the research of stroke.
For research use only. We do not sell to patients.
- CAS No.: 342434-07-5
- Formula: C18H19ClN4O
- Molecular Weight:342.83
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
B-Raf 4.8 nM (Kd) |
B-Raf 6 nM (IC50) |
In Vitro
B-Raf-IN-21 (compound 8) potently inhibits B-Raf kinase with an IC50 of 6 nM in a cell-free kinase activity assay[1].
B-Raf-IN-21 binds to B-Raf with a Kd of 4.8 nM in a cell-free fluorescent polarization ligand binding assay[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 342434-07-5
-
Molecular Weight 342.83
-
Formula C18H19ClN4O
-
SMILES
ClC=1C=CC(=CC1O)C=2NC(=NC2C=3C=CN=CC3)C(C)(C)CN
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)